Insider Buying in an Active M&A Situation – Insider Weekends
Quanterix Corp (QTRX): $6.06
Market Cap: $235.31M
Enterprise Value: $4.84M
Key Insights
- An unusual insider purchase of Bauch Health (the old Valeant Pharmaceuticals) by the hedge fund legend John Paulson
- Quanterix insiders, including the CEO and co-founder David Walt, made significant purchases despite ongoing controversy over the Akoya acquisition and activist opposition to the deal
- Quanterix currently trades below net cash on the balance sheet
Only plus or premium subscribers can access this post. Subscribe today.
